Rofecoxib may cause heart attacks in first weeks of use
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7550.1114 (Published 11 May 2006) Cite this as: BMJ 2006;332:1114- Janice Hopkins Tanne
- New York
A small but significant number of elderly people who began taking rofecoxib (Vioxx) had heart attacks in the first two weeks, a study has found. Previously the risk was thought to occur only after 18 months of treatment.
The study was posted online ahead of publication on 2 May by the CMAJ, the journal of the Canadian Medical Association (http://www.cmaj.ca/, doi: 10.1503/cmaj.051 679).
“A small proportion of patients using rofecoxib for the first time had their first MI [myocardial infarction] shortly after starting the drug,” the paper says. The risk was highest in the first six to 13 days (median nine days) after they started treatment with the drug. The risk did not increase …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.